open access

Vol 4, No 3 (2002)
Published online: 2002-11-08
Get Citation

Endoscopic sclerotherapy in control of variceal hemorrhage: a prospective trial in nonselected cirrhotic patients

Maciej Gonciarz, Jacek Hartleb, Dariusz Gil, Aleksander Michalski, Jan Pruszowski, Jerzy Goniewicz, Anna Witiuk-Misztalska, Aldona Mularczyk, Włodzimierz Mazur, Michał Petelenz
Chirurgia Polska 2002;4(3):99-106.

open access

Vol 4, No 3 (2002)
Published online: 2002-11-08

Abstract

Background: Among many therapeutic regimens EVS (endoscopic variceal sclerotherapy) and EVL (endoscopic variceal ligation) are known to be the most effective treatments in variceal haemorrhage (75% to 95%) caused by liver cirrhosis.
The aim of this study was to determine the EVS efficacy in the eradication and treatment of bleeding oesophageal varices in patients who underwent endoscopic control in two months during follow-up.
Material and methods: Between 1991 and 2000 a total number of 271 patients of different cirrhosis aetiology (viral 63%, alcoholic 26%, AIH 3.7%, PBC 3%, cryptogenic 3.7%) underwent EVS procedure in two parts. In bleed the first, EVS was done in 3-day intervals up to variceal eradication (no more than 10 procedures) or up to EVS complications. In the cases of no variceal eradication, the second part of treatment was introduced (no more then 10 sclerotherapies). After that, the patients were endoscopically followed up for 48 months in two-month intervals. Retreatment using EVS was introduced if variceal recurrence was found.
Results: Acute haemostasis was achieved in 259 out of 271 patients (95.6%). Six patients died within the first 48 hours of hospitalisation. 131 patients were endoscopically followed up for 48 months regularly while the remaining 101 patients irregularly. 27 patients were lost, there was no information about them. Rebleeding occurred in 52 patients (22.5%). Rebleeding was noted in 32% of patients irregularly followed and in 16% regularly followed (p > 0.05). 77.5% of patients with rebleeding had no full variceal eradication.
Conclusion: EVS is very effective procedure in initial control of oesophageal variceal bleeding. It could also be effective in preventing of rebleeding if endoscopy and EVS are regularly performed in two-month intervals during follow-up.

Abstract

Background: Among many therapeutic regimens EVS (endoscopic variceal sclerotherapy) and EVL (endoscopic variceal ligation) are known to be the most effective treatments in variceal haemorrhage (75% to 95%) caused by liver cirrhosis.
The aim of this study was to determine the EVS efficacy in the eradication and treatment of bleeding oesophageal varices in patients who underwent endoscopic control in two months during follow-up.
Material and methods: Between 1991 and 2000 a total number of 271 patients of different cirrhosis aetiology (viral 63%, alcoholic 26%, AIH 3.7%, PBC 3%, cryptogenic 3.7%) underwent EVS procedure in two parts. In bleed the first, EVS was done in 3-day intervals up to variceal eradication (no more than 10 procedures) or up to EVS complications. In the cases of no variceal eradication, the second part of treatment was introduced (no more then 10 sclerotherapies). After that, the patients were endoscopically followed up for 48 months in two-month intervals. Retreatment using EVS was introduced if variceal recurrence was found.
Results: Acute haemostasis was achieved in 259 out of 271 patients (95.6%). Six patients died within the first 48 hours of hospitalisation. 131 patients were endoscopically followed up for 48 months regularly while the remaining 101 patients irregularly. 27 patients were lost, there was no information about them. Rebleeding occurred in 52 patients (22.5%). Rebleeding was noted in 32% of patients irregularly followed and in 16% regularly followed (p > 0.05). 77.5% of patients with rebleeding had no full variceal eradication.
Conclusion: EVS is very effective procedure in initial control of oesophageal variceal bleeding. It could also be effective in preventing of rebleeding if endoscopy and EVS are regularly performed in two-month intervals during follow-up.
Get Citation

Keywords

liver cirrhosis; endoscopic variceal sclerotherapy

About this article
Title

Endoscopic sclerotherapy in control of variceal hemorrhage: a prospective trial in nonselected cirrhotic patients

Journal

Chirurgia Polska (Polish Surgery)

Issue

Vol 4, No 3 (2002)

Pages

99-106

Published online

2002-11-08

Bibliographic record

Chirurgia Polska 2002;4(3):99-106.

Keywords

liver cirrhosis
endoscopic variceal sclerotherapy

Authors

Maciej Gonciarz
Jacek Hartleb
Dariusz Gil
Aleksander Michalski
Jan Pruszowski
Jerzy Goniewicz
Anna Witiuk-Misztalska
Aldona Mularczyk
Włodzimierz Mazur
Michał Petelenz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaBy "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl